In addition, infiltration of peritumoral lymphatic and venous vessels, the presence of estrogen (ER), progesterone (PR), and epidermal growth factor receptor 2 (HER2), the Ki67 proliferation index, and a panel of biomarkers that determine the molecular subtype of breast cancer are also assessed [4,5]. The gene discussed is ERBB2; the disease is breast carcinoma.